What Has Been the Progress and Growth of the Hyperpigmentation Disorder Treatment Market in Recent Years?
The hyperpigmentation disorder treatment market has seen considerable growth due to a variety of factors.
•There has been a substantial growth in the market size for the treatment of hyperpigmentation disorders in the past few years. It is projected to escalate from $5.73 billion in 2024 to $6.14 billion in 2025 with a compound annual growth rate (CAGR) of 7.1%.
The historical growth in this market can be traced back to factors such as scientific research and clinical trials, advancements in chemical peels, a cultural inclination towards skincare, a focus on non-invasive procedures, and a growing demand for natural products.
What Can Be Expected from the Hyperpigmentation Disorder Treatment Market in the Coming Years?
The hyperpigmentation disorder treatment market is expected to maintain its strong growth trajectory in upcoming years.
• The market for treating hyperpigmentation disorders is anticipated to exhibit robust growth in the forthcoming years, reaching a value of "$8.6 billion by 2029 with an 8.8% compound annual growth rate (CAGR).
This increase during the predicted period can be associated with the emphasis on non-surgical treatment options, an increased understanding of skincare, the implementation of telemedicine and virtual consultations, regulatory backing and approvals for treatments, as well as tailored treatment possibilities. The major projected trends for this period involve the creation of innovative topical solutions, progress in laser technologies, a shift toward combined therapy strategies, personalized treatment plans, and a growing interest in natural products.
What Are the Critical Driver Fuelling the Hyperpigmentation Disorder Treatment Market's Growth?
The hyperpigmentation disorders treatment market is predicted to grow due to an increasing prevalence of pigmentation disorders. Such disorders, affecting the color of skin, hair, and eye iris, occur due to problems with melanin, the pigment that determines the color of skin, hair, and eyes. The treatments for hyperpigmentation disorders often depend on the cause and severity of the issue. Milder cases can frequently be treated with over-the-counter topical creams containing substances such as azelaic acid, cysteamine cream, vitamin C, and hydroquinone, known for their skin-lightening effects. A study from the subscription-based Wiley Online Library in the US highlighted in May 2024, that about 50% of the worldwide population has at least one pigmented disorder, affecting women more frequently (59%). In Australia, 48% of people report having at least one such disorder, with solar lentigo being the most common, impacting 37% of Australians. Hence, an escalating incidence of pigment disorders is anticipated to fuel the growth of the hyperpigmentation disorders treatment market.
How Is the Hyperpigmentation Disorder Treatment Market segmented?
The hyperpigmentation disorder treatment market covered in this report is segmented –
1) By Treatment Type: Cosmeceuticals, Laser Therapy, Chemical Peels, Microdermabrasion, Phototherapy, Other Treatments
2) By Disease Indication: Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines, Other Disease Indications
3) By End-Users: Hospitals, Esthetic Clinics And Dermatology Centers, Other End-Users
Subsegments:
1) By Cosmeceuticals: Topical Creams and Gels, Serums and Lotions, Sunscreens, Laser Therapy
2) By Laser Therapy: Fractional Laser Resurfacing, Intense Pulsed Light (IPL) Therapy
3) By Chemical Peels: Superficial Peels, Medium Depth Peels, Deep Peels
4) By Microdermabrasion: Crystal Microdermabrasion, Diamond Microdermabrasion
5) By Phototherapy: Blue Light Therapy, Red Light Therapy
6) By Other Treatments: Cryotherapy, Dermal Fillers, Microneedling
Pre-Book The Hyperpigmentation Disorder Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing the Hyperpigmentation Disorder Treatment Market?
Companies dominant in the hyperpigmentation disorders treatment market are concentrating on generating glycolic acid solutions to amplify their market stance and secure a competitive edge. Glycolic acid solutions are skincare concoctions inclusive of glycolic acid - an alpha hydroxy acid (AHA) recognized for its exfoliating attributes, enhancing skin texture, brightness, and overall look by stimulating cell turnover. As an illustration, L'Oréal SA, a France-based personal care company, unveiled the Glycolic Bright Dark Circle Eye Serum in February 2024. The serum, designed to alleviate dark circles and dullness around the eye region, is enriched with glycolic acid for its exfoliating benefits, resulting in brighter skin and enhanced texture. The serum's composition likely contains moisturizing components to feed the sensitive eye area.
Who Are the Key Players in the Hyperpigmentation Disorder Treatment Market?
Major companies operating in the hyperpigmentation disorder treatment market include:
• Vivier Pharma
• Obagi Cosmeceuticals LLC
• RXi Pharmaceuticals Corporation
• EpiPharm AG
• Laboratories Pierre Fabre
• SkinCeuticals
• Galderma S.A.
• Allergan PLC.
• Bayer AG
• Lumenis Be Ltd.
• Aerolase Corporation
• Candela Corporation
• Cynosure
• PCA Skin
• Episciences Inc.
• La Roche-Posay
• L'Oréal S.A.
• Pierre Fabre Laboratories
• Alvogen Inc.
• Clinuvel Pharmaceuticals Ltd.
• Clarify Medical Inc.
• Incyte Corporation
• Dr. Reddy’s Laboratories Ltd.
• Glenmark Pharmaceuticals Ltd.
• Teva Pharmaceutical Industries
• SkinMedica Inc.
• Neutrogena Corporation
• Paula's Choice Inc.
• ZO Skin Health Inc.
• Estée Lauder Companies Inc.
What Is The Most Dominant Region In The Hyperpigmentation Disorder Treatment Market?
North America was the largest region in the hyperpigmentation disorders treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global hyperpigmentation disorder treatment market report during the forecast period. The regions covered in the hyperpigmentation disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
